Vesna Supak Smolcic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Vesna Supak Smolcic has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Lidija Bilic-Zulle
Clinical Institute of Laboratory Diagnostics, Rijeka Clinical Hospital Center, Rijeka, Croatia; Department of Medical Informatics, Rijeka University School of Medicine, Rijeka, Croatia
9 shared publications - Ana-Maria Simundic
Department of Medical Laboratory Diagnostics, University Hospital ‘Sveti Duh’, 10000 Zagreb, Croatia
5 shared publications - Nora Nikolac
Department of Clinical Chemistry, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia
4 shared publications Ana-Maria Simundic
Editor-in-chief, Biochemia Medica ; Department of Medical Laboratory Diagnostics, University Hospital "Sveti Duh", Zagreb, Croatia
2 shared publicationsDragana Antončić
Clinical Department of Laboratory Diagnostics , Clinical Hospital Center Rijeka , Rijeka , Croatia
2 shared publications- Dragana Antončić
Clinical Department of Laboratory Diagnostics, Clinical Hospital Centre Rijeka, Rijeka, Croatia
2 shared publications
Latest Publications
- 3 August 2026
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
Continuous reference curves for hematology and biochemistry analytes in pregnancy – a prospective study
Objectives: Pregnancy involves dynamic metabolic changes that cannot be accurately interpreted using population reference intervals (RI). The aim was to develop continuous reference curves for common hematology and biochemistry laboratory analytes in pregnancy and to assess their agreement with the RIs for non-pregnant women, which are routinely reported for pregnant women. Methods: A prospective study was conducted at the Clinical Hospital Centre Rijeka, Croatia, from September 2022 to December 2025. Inclusion criteria were age ≥18 years, singleton pregnancy, normal ultrasound and prenatal screening findings, and favorable pregnancy outcome. Exclusion criteria were illness in the last month, pregnancy-related complications, medically assisted fertilization, and chronic medication use. All participants provided informed consent and completed a questionnaire on lifestyle habits and health status. Continuous reference curves for 43 laboratory analytes were generated using the mathematical-statistical GAMLSS model. Agreement with the discrete RI was expressed as the percentage deviation from the continuous reference curves. Results: The analysis included 739 samples from 542 pregnant women between the 11th and 38th gestational weeks. Of the 43 laboratory analytes, 35 showed discrepancies when compared to non-pregnant RI. Falsely elevated interpretations ranged from 5.6 to 64.9 %, and falsely lowered from 3.4 to 62.0 %. Graphical representations of the continuous reference curves show pronounced dynamics compared to the existing discrete RI. Conclusions: The use of RIs for non-pregnant women results in substantial differences in the interpretation of laboratory results in pregnant women. Continuous gestational age-specific reference curves account for nonlinear physiological changes and provide a physiologically appropriate framework for interpreting laboratory results during pregnancy.
- 3 August 2026
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
Continuous reference curves for hematology and biochemistry analytes in pregnancy – a prospective study
Objectives: Pregnancy involves dynamic metabolic changes that cannot be accurately interpreted using population reference intervals (RI). The aim was to develop continuous reference curves for common hematology and biochemistry laboratory analytes in pregnancy and to assess their agreement with the RIs for non-pregnant women, which are routinely reported for pregnant women. Methods: A prospective study was conducted at the Clinical Hospital Centre Rijeka, Croatia, from September 2022 to December 2025. Inclusion criteria were age ≥18 years, singleton pregnancy, normal ultrasound and prenatal screening findings, and favorable pregnancy outcome. Exclusion criteria were illness in the last month, pregnancy-related complications, medically assisted fertilization, and chronic medication use. All participants provided informed consent and completed a questionnaire on lifestyle habits and health status. Continuous reference curves for 43 laboratory analytes were generated using the mathematical-statistical GAMLSS model. Agreement with the discrete RI was expressed as the percentage deviation from the continuous reference curves. Results: The analysis included 739 samples from 542 pregnant women between the 11th and 38th gestational weeks. Of the 43 laboratory analytes, 35 showed discrepancies when compared to non-pregnant RI. Falsely elevated interpretations ranged from 5.6 to 64.9 %, and falsely lowered from 3.4 to 62.0 %. Graphical representations of the continuous reference curves show pronounced dynamics compared to the existing discrete RI. Conclusions: The use of RIs for non-pregnant women results in substantial differences in the interpretation of laboratory results in pregnant women. Continuous gestational age-specific reference curves account for nonlinear physiological changes and provide a physiologically appropriate framework for interpreting laboratory results during pregnancy.
- Open Access
The Role of Interleukin-13 in Chronic Airway Diseases: A Cross-Sectional Study in COPD and Asthma–COPD Overlap
Background: Distinguishing chronic obstructive pulmonary disease (COPD) from asthma–COPD overlap (ACO) remains challenging due to shared clinical and inflammatory features. Interleukin-13 (IL-13) is implicated in airway inflammation and remodeling and may represent a potential treatable trait. This study aimed to evaluate whether serum IL-13 could differentiate between COPD and ACO or define ACO subtypes and to explore its relationship with clinical and phenotype parameters. Materials and Methods: We conducted a cross-sectional bicentric study in 215 COPD and ACO patients recruited from outpatient clinics. The study measured blood IL-13 levels in COPD vs. ACO patients, across five ACO subtypes, and evaluated IL-13’s ability to predict ACO. Additionally, correlations were explored among endotype (IL-13) and different phenotype traits (e.g., fractional exhaled nitric oxide (FeNO), sputum eosinophilia, serum total immunoglobulin E (tIgE) levels, blood eosinophilia, and neutrophilia) and clinical outcomes (annualized exacerbation rate, symptom scores, and pulmonary function parameters). Results: No significant differences in IL-13 levels were found between COPD and ACO patients or among ACO subtypes. IL-13 did not predict ACO occurrence. We observed a weak correlation between IL-13 and tIgE levels in the entire cohort. Additionally, there was a weak correlation between IL-13 and FeNO in patients with eosinophil counts exceeding 300 cells/μL, as well as between IL-13 and age in the COPD cohort. No correlation was found between IL-13 and other phenotypic features or clinical outcomes in the overall cohort, including within both COPD and ACO groups. Conclusions: IL-13 cannot differentiate between COPD and ACO or ACO’s subtypes.
Open AccessThe Role of Interleukin-13 in Chronic Airway Diseases: A Cross-Sectional Study in COPD and Asthma–COPD Overlap
Background: Distinguishing chronic obstructive pulmonary disease (COPD) from asthma–COPD overlap (ACO) remains challenging due to shared clinical and inflammatory features. Interleukin-13 (IL-13) is implicated in airway inflammation and remodeling and may represent a potential treatable trait. This study aimed to evaluate whether serum IL-13 could differentiate between COPD and ACO or define ACO subtypes and to explore its relationship with clinical and phenotype parameters. Materials and Methods: We conducted a cross-sectional bicentric study in 215 COPD and ACO patients recruited from outpatient clinics. The study measured blood IL-13 levels in COPD vs. ACO patients, across five ACO subtypes, and evaluated IL-13’s ability to predict ACO. Additionally, correlations were explored among endotype (IL-13) and different phenotype traits (e.g., fractional exhaled nitric oxide (FeNO), sputum eosinophilia, serum total immunoglobulin E (tIgE) levels, blood eosinophilia, and neutrophilia) and clinical outcomes (annualized exacerbation rate, symptom scores, and pulmonary function parameters). Results: No significant differences in IL-13 levels were found between COPD and ACO patients or among ACO subtypes. IL-13 did not predict ACO occurrence. We observed a weak correlation between IL-13 and tIgE levels in the entire cohort. Additionally, there was a weak correlation between IL-13 and FeNO in patients with eosinophil counts exceeding 300 cells/μL, as well as between IL-13 and age in the COPD cohort. No correlation was found between IL-13 and other phenotypic features or clinical outcomes in the overall cohort, including within both COPD and ACO groups. Conclusions: IL-13 cannot differentiate between COPD and ACO or ACO’s subtypes.
- Open Access
- 8 February 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (4) , 415
Reference Intervals for Common Biochemistry and Hematology Parameters in Early Pregnancy—A Prospective Study
Background: The aim of this study was the determination of reference values for the common laboratory parameters in early pregnancy using a direct method and to assess their clinically significant difference, which was compared to the reference intervals for non-pregnant women with respect to the reference change value (RCV). Methods: This study was conducted from September 2022 to December 2023 at the Clinical Department of Laboratory Diagnostics, Clinical Hospital Centre RIJEKA, Croatia. The inclusion criteria were as follows: age ≥ 18 years, singleton pregnancy, normal ultrasound examination, and prenatal screening. The exclusion criteria were as follows: recent illness, pregnancy-related complications, medically assisted reproduction, and medication use. The reference intervals were established using the non-parametric percentile method according to the CLSI EP28-A3c recommendation. The reference values were compared to those of non-pregnant women and judged against RCV values based on biological variation. Additionally, we tested the influence of food consumption and oral supplements. Results: The data of 299 participants were included in the study. Laboratory tests whose changes are clinically relevant lower in early pregnancy are as follows: hemoglobin, MCV, hematocrit, MCH, urea, creatinine, albumin, alkaline phosphatase, lactate dehydrogenase, sodium, and magnesium. The clinically relevant higher values are as follows: RDW, total leukocyte count, neutrophil granulocytes, monocytes, CRP, total cholesterol, triglycerides, and amylase. UIBC has a wider reference range. The consumption of food and supplements has no clinically significant influence in relation to the RCV. Conclusions: Establishing reference intervals in pregnancy remains a challenge due to the metabolic changes during pregnancy, as well as its clinical significance.
- 8 February 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (4) , 415
Open AccessReference Intervals for Common Biochemistry and Hematology Parameters in Early Pregnancy—A Prospective Study
Background: The aim of this study was the determination of reference values for the common laboratory parameters in early pregnancy using a direct method and to assess their clinically significant difference, which was compared to the reference intervals for non-pregnant women with respect to the reference change value (RCV). Methods: This study was conducted from September 2022 to December 2023 at the Clinical Department of Laboratory Diagnostics, Clinical Hospital Centre RIJEKA, Croatia. The inclusion criteria were as follows: age ≥ 18 years, singleton pregnancy, normal ultrasound examination, and prenatal screening. The exclusion criteria were as follows: recent illness, pregnancy-related complications, medically assisted reproduction, and medication use. The reference intervals were established using the non-parametric percentile method according to the CLSI EP28-A3c recommendation. The reference values were compared to those of non-pregnant women and judged against RCV values based on biological variation. Additionally, we tested the influence of food consumption and oral supplements. Results: The data of 299 participants were included in the study. Laboratory tests whose changes are clinically relevant lower in early pregnancy are as follows: hemoglobin, MCV, hematocrit, MCH, urea, creatinine, albumin, alkaline phosphatase, lactate dehydrogenase, sodium, and magnesium. The clinically relevant higher values are as follows: RDW, total leukocyte count, neutrophil granulocytes, monocytes, CRP, total cholesterol, triglycerides, and amylase. UIBC has a wider reference range. The consumption of food and supplements has no clinically significant influence in relation to the RCV. Conclusions: Establishing reference intervals in pregnancy remains a challenge due to the metabolic changes during pregnancy, as well as its clinical significance.
- 26 December 2022
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 61 (6) , 1046-1053
Serum bicarbonate stability study at room temperature – influence of time to centrifugation and air exposure on bicarbonate measurement reported according to the CRESS checklist
Objectives: The aim was to evaluate the stability of serum bicarbonate at room temperature, depending on time to centrifugation and air exposure. Methods: Stability study was conducted in the laboratory of Clinical Hospital Centre Rijeka, Croatia in January-February 2022. Nine samples from 10 volunteers were collected in clot activator gel tubes (Greiner Bio-One). Bicarbonate was measured on Beckman Coulter AU480 (Beckman Coulter, Brea, USA). Three tubes were left at room temperature for 30 min, three tubes for 2 h, three tubes for 4 h until centrifugation. First tube from first group (baseline) was measured immediately after centrifugation. Other measurements were expressed as percentage deviation (PD%) from baseline. First tube was remeasured after 1 and 2 h (OT_0h_1h; OT_0h_2h). Second and third tubes were opened 1 and 2 h after centrifugation (C_0h_1h; C_0h_2h). Second group of tubes was processed the same way with 2-hour centrifugation delay (WB_2h; OT_2h_1h; OT_2h_2h; C_2h_1h; C_2h_2h), and third group with 4-hour delay (WB_4h; OT_4h_1h; OT_4h_2h; C_4h_1h; C_4h_2h). PD% was compared to Maximum Permissible Difference (MPD=5.69%). MedCalc statistical software was used (MedCalc, Ostend, Belgium). Results: Bicarbonate baseline mean value (range) was 27.3 (23.4–29.6) mmol/L. Obtained PD% (95%CI) were: C_0h_1h 0.46 (−1.21, 2.12); C_0h_2h 0.18 (−2.22, 2.57); OT_0h_1h −6.46 (−7.57, −5.36); OT_0h_2h −10.67 (−12.13, −9.21); WB_2h −0.15 (−2.04, 1.74); C_2h_1h 0.01 (−1.52, 1.54); C_2h_2h −0.40 (−2.65, 1.85); OT_2h_1h −5.43 (−7.30, −3.55); OT_2h_2h −11.32 (−13.57, −9.07); WB_4h −0.85 (−3.28, 1.58); C_4h_1h −2.52 (−4.93, 0.11); C_4h_2h −3.02 (−5.62, 0.43); OT_4h_1h −7.34 (−9.64, −5.05); OT_4h_2h −11.85 (−14.38, −9.33). Conclusions: Serum bicarbonate is stable for 4 h in closed uncentrifuged tubes, another 2 h in closed tubes after centrifugation, and is unstable within 1 h in opened tube.
- 26 December 2022
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 61 (6) , 1046-1053
Serum bicarbonate stability study at room temperature – influence of time to centrifugation and air exposure on bicarbonate measurement reported according to the CRESS checklist
Objectives: The aim was to evaluate the stability of serum bicarbonate at room temperature, depending on time to centrifugation and air exposure. Methods: Stability study was conducted in the laboratory of Clinical Hospital Centre Rijeka, Croatia in January-February 2022. Nine samples from 10 volunteers were collected in clot activator gel tubes (Greiner Bio-One). Bicarbonate was measured on Beckman Coulter AU480 (Beckman Coulter, Brea, USA). Three tubes were left at room temperature for 30 min, three tubes for 2 h, three tubes for 4 h until centrifugation. First tube from first group (baseline) was measured immediately after centrifugation. Other measurements were expressed as percentage deviation (PD%) from baseline. First tube was remeasured after 1 and 2 h (OT_0h_1h; OT_0h_2h). Second and third tubes were opened 1 and 2 h after centrifugation (C_0h_1h; C_0h_2h). Second group of tubes was processed the same way with 2-hour centrifugation delay (WB_2h; OT_2h_1h; OT_2h_2h; C_2h_1h; C_2h_2h), and third group with 4-hour delay (WB_4h; OT_4h_1h; OT_4h_2h; C_4h_1h; C_4h_2h). PD% was compared to Maximum Permissible Difference (MPD=5.69%). MedCalc statistical software was used (MedCalc, Ostend, Belgium). Results: Bicarbonate baseline mean value (range) was 27.3 (23.4–29.6) mmol/L. Obtained PD% (95%CI) were: C_0h_1h 0.46 (−1.21, 2.12); C_0h_2h 0.18 (−2.22, 2.57); OT_0h_1h −6.46 (−7.57, −5.36); OT_0h_2h −10.67 (−12.13, −9.21); WB_2h −0.15 (−2.04, 1.74); C_2h_1h 0.01 (−1.52, 1.54); C_2h_2h −0.40 (−2.65, 1.85); OT_2h_1h −5.43 (−7.30, −3.55); OT_2h_2h −11.32 (−13.57, −9.07); WB_4h −0.85 (−3.28, 1.58); C_4h_1h −2.52 (−4.93, 0.11); C_4h_2h −3.02 (−5.62, 0.43); OT_4h_1h −7.34 (−9.64, −5.05); OT_4h_2h −11.85 (−14.38, −9.33). Conclusions: Serum bicarbonate is stable for 4 h in closed uncentrifuged tubes, another 2 h in closed tubes after centrifugation, and is unstable within 1 h in opened tube.
- 15 February 2022
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 60 (5) , 714-725
Comparison of three different protocols for obtaining hemolysis
Objectives: Hemolysis is associated with erroneous or delayed results. Objectives of the study were to compare four different methods for obtaining hemolysis in vitro on three different analyzers. Methods: Hemolysis was prepared with addition of pure hemoglobin into serum pool, osmotic shock, aspiration through blood collection needle, freezing/thawing of whole blood. Biochemistry parameters were measured in duplicate at Architect c8000 (Abbott, Abbott Park, USA), Beckman Coulter AU680 (Beckman Coulter, Brea, USA) and Cobas 6000 c501 (Roche, Mannheim, Germany), according to manufacturers’ declarations. Cut-off value was defined as the highest value of H index with corresponding bias lower than acceptance criteria. Results: We were not able to obtain results with freezing protocol. On all three platforms, lowest number of analytes were sensitive to hemolysis at H=0.5 using method of adding free hemoglobin. When osmotic shock was used, cut-off values for the most analytes were generally met at lower values. Hemolysis significantly interfered with measurement of potassium and lactate dehydrogenase (LD) at H=0.5 on all platforms. The most of the tested analytes had the lowest acceptable H index when aspiration method was used. At the low level of hemolysis (H=0.8) glucose, sodium, potassium, chloride, phosphate, and LD were affected on all analyzers, with some additional analytes depending on the manufacturer. Conclusions: Hemolysis interference differs on different analyzers and according to protocol for obtaining hemolysis. Aspiration method was generally the most sensitive to hemolysis interference, while addition of free Hb was the most resistant.
- 15 February 2022
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 60 (5) , 714-725
Comparison of three different protocols for obtaining hemolysis
Objectives: Hemolysis is associated with erroneous or delayed results. Objectives of the study were to compare four different methods for obtaining hemolysis in vitro on three different analyzers. Methods: Hemolysis was prepared with addition of pure hemoglobin into serum pool, osmotic shock, aspiration through blood collection needle, freezing/thawing of whole blood. Biochemistry parameters were measured in duplicate at Architect c8000 (Abbott, Abbott Park, USA), Beckman Coulter AU680 (Beckman Coulter, Brea, USA) and Cobas 6000 c501 (Roche, Mannheim, Germany), according to manufacturers’ declarations. Cut-off value was defined as the highest value of H index with corresponding bias lower than acceptance criteria. Results: We were not able to obtain results with freezing protocol. On all three platforms, lowest number of analytes were sensitive to hemolysis at H=0.5 using method of adding free hemoglobin. When osmotic shock was used, cut-off values for the most analytes were generally met at lower values. Hemolysis significantly interfered with measurement of potassium and lactate dehydrogenase (LD) at H=0.5 on all platforms. The most of the tested analytes had the lowest acceptable H index when aspiration method was used. At the low level of hemolysis (H=0.8) glucose, sodium, potassium, chloride, phosphate, and LD were affected on all analyzers, with some additional analytes depending on the manufacturer. Conclusions: Hemolysis interference differs on different analyzers and according to protocol for obtaining hemolysis. Aspiration method was generally the most sensitive to hemolysis interference, while addition of free Hb was the most resistant.
- Open Access
- 1 January 2016
- Published by Croatian Society for Medical Biochemistry and Laboratory Medicine in Biochemia Medica
- Vol. 26 (2) , 147-149
Identification of authors without surnames: is ORCID the right way forward?
Identification of authors without surnames: is ORCID the right way forward?
- 1 January 2016
- Published by Croatian Society for Medical Biochemistry and Laboratory Medicine in Biochemia Medica
- Vol. 26 (2) , 147-149
Open AccessIdentification of authors without surnames: is ORCID the right way forward?
Identification of authors without surnames: is ORCID the right way forward?
- 1 August 2015
- Published by Springer Nature in Science and Engineering Ethics
- Vol. 22 (4) , 1095-1106
An Analysis of Medical Laboratory Technology Journals’ Instructions for Authors
Instructions for authors (IFA) need to be informative and regularly updated. We hypothesized that journals with a higher impact factor (IF) have more comprehensive IFA. The aim of the study was to examine whether IFA of journals indexed in the Journal Citation Reports 2013, “Medical Laboratory Technology” category, are written in accordance with the latest recommendations and whether the quality of instructions correlates with the journals’ IF. 6 out of 31 journals indexed in “Medical Laboratory Technology” category were excluded (unsuitable or unavailable instructions). The remaining 25 journals were scored based on a set of 41 yes/no questions (score 1/0) and divided into four groups (editorial policy, research ethics, research integrity, manuscript preparation) by three authors independently (max score = 41). We tested the correlation between IF and total score and the difference between scores in separate question groups. The median total score was 26 (21–30) [portion of positive answers 0.63 (0.51–0.73)]. There was no statistically significant correlation between a journal’s IF and the total score (rho = 0.291, P = 0.159). IFA included recommendations concerning research ethics and manuscript preparation more extensively than recommendations concerning editorial policy and research integrity (Ht = 15.91, P = 0.003). Some policies were poorly described (portion of positive answers), for example: procedure for author’s appeal (0.04), editorial submissions (0.08), appointed body for research integrity issues (0.08). The IF of the “Medical Laboratory Technology” journals does not reflect a journals’ compliance to uniform standards. There is a need for improving editorial policies and the policies on research integrity.
- 1 August 2015
- Published by Springer Nature in Science and Engineering Ethics
- Vol. 22 (4) , 1095-1106
An Analysis of Medical Laboratory Technology Journals’ Instructions for Authors
Instructions for authors (IFA) need to be informative and regularly updated. We hypothesized that journals with a higher impact factor (IF) have more comprehensive IFA. The aim of the study was to examine whether IFA of journals indexed in the Journal Citation Reports 2013, “Medical Laboratory Technology” category, are written in accordance with the latest recommendations and whether the quality of instructions correlates with the journals’ IF. 6 out of 31 journals indexed in “Medical Laboratory Technology” category were excluded (unsuitable or unavailable instructions). The remaining 25 journals were scored based on a set of 41 yes/no questions (score 1/0) and divided into four groups (editorial policy, research ethics, research integrity, manuscript preparation) by three authors independently (max score = 41). We tested the correlation between IF and total score and the difference between scores in separate question groups. The median total score was 26 (21–30) [portion of positive answers 0.63 (0.51–0.73)]. There was no statistically significant correlation between a journal’s IF and the total score (rho = 0.291, P = 0.159). IFA included recommendations concerning research ethics and manuscript preparation more extensively than recommendations concerning editorial policy and research integrity (Ht = 15.91, P = 0.003). Some policies were poorly described (portion of positive answers), for example: procedure for author’s appeal (0.04), editorial submissions (0.08), appointed body for research integrity issues (0.08). The IF of the “Medical Laboratory Technology” journals does not reflect a journals’ compliance to uniform standards. There is a need for improving editorial policies and the policies on research integrity.
- Open Access
- 1 January 2015
- Published by Croatian Society for Medical Biochemistry and Laboratory Medicine in Biochemia Medica
- Vol. 25 (3) , 324-334
ICMJE authorship criteria are not met in a substantial proportion of manuscripts submitted to Biochemia Medica
ICMJE authorship criteria are not met in a substantial proportion of manuscripts submitted to
- 1 January 2015
- Published by Croatian Society for Medical Biochemistry and Laboratory Medicine in Biochemia Medica
- Vol. 25 (3) , 324-334
Open AccessICMJE authorship criteria are not met in a substantial proportion of manuscripts submitted to Biochemia Medica
ICMJE authorship criteria are not met in a substantial proportion of manuscripts submitted to
- 1 January 2015
- Published by Elsevier in Clinical Biochemistry
- Vol. 48 (1-2) , 85-88
Influence of a prolonged fasting and mild activity on routine laboratory tests
- 1 January 2015
- Published by Elsevier in Clinical Biochemistry
- Vol. 48 (1-2) , 85-88
Influence of a prolonged fasting and mild activity on routine laboratory tests
- Open Access
- 1 January 2013
- Published by Croatian Society for Medical Biochemistry and Laboratory Medicine in Biochemia Medica
- Vol. 23 (3) , 237-241
Salami publication: definitions and examples
Salami publication or segmented publication is a distinct form of redundant publication which is usually characterized by similarity of hypothesis, methodology or results but not text similarity. These aspects of publications are not objectively detected by software applications and therefore present a serious threat to publication ethics. This article presents a practical approach for dealing with manuscripts suspected of salami publication during the submission process and after article publication in Biochemia Medica.
- 1 January 2013
- Published by Croatian Society for Medical Biochemistry and Laboratory Medicine in Biochemia Medica
- Vol. 23 (3) , 237-241
Open AccessSalami publication: definitions and examples
Salami publication or segmented publication is a distinct form of redundant publication which is usually characterized by similarity of hypothesis, methodology or results but not text similarity. These aspects of publications are not objectively detected by software applications and therefore present a serious threat to publication ethics. This article presents a practical approach for dealing with manuscripts suspected of salami publication during the submission process and after article publication in Biochemia Medica.